Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional ...
A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an ...
Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional ...
Key Takeaways Medical imaging contrast agents are contributing to water pollutionMedicare patients alone received 13.5 ...
Columbia physicist Isidor Isaac Rabi discovered nuclear magnetic resonance in the 1930s. Today, it lets doctors look inside ...